Telmisartan Plus Tablet 40/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, this medication should be taken once daily with water, regardless of meals. It is recommended to adjust the dosage of each component individually before switching to this combination medication, which has fixed doses of each component. When clinically appropriate, direct switching from monotherapy to this combination medication may also be considered. - Telmisartan/Hydrochlorothiazide combination 40/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40 mg. - Telmisartan/Hydrochlorothiazide combination 80/12.5 mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80 mg. - Telmisartan/Hydrochlorothiazide combination 80/25 mg may be administered to patients whose blood pressure is not adequately controlled with a combination of telmisartan 80 mg and hydrochlorothiazide 12.5 mg. It is essential to correct sodium depletion or volume depletion before starting therapy with this medication.

Child dose

Safety and efficacy of this medication have not been established in children under 18 years of age.

This medication should be discontinued immediately upon confirmation of pregnancy, especially in the second and third trimesters as it can cause severe harm to the fetus. This medication should not be administered to individuals with specific allergic conditions, pregnant or nursing women, and patients with severe liver or kidney disease. Careful use is required in elderly patients or those with high potassium levels, impaired liver function, or patients with cardiac or vascular diseases. This medication lowers blood pressure and may cause symptoms of hypotension, dizziness, or fainting, necessitating attention to such symptoms during use. Due to the hydrochlorothiazide component, electrolyte imbalances may occur; regular blood tests should be conducted to monitor electrolyte levels. This medication may interact with other antihypertensives, certain diuretics, lithium, potassium supplements, and thus it is essential to inform your doctor or pharmacist about any currently taken medications. Caution is needed as dizziness or drowsiness may occur while driving or operating machinery. Safety and efficacy of this medication have not been established for children, and it is not recommended for them. In case of overdose, hypotension, electrolyte imbalance, dehydration, etc., may occur, so the prescribed dosage must be observed, and consultation with healthcare professionals should occur in case of abnormal symptoms. When storing, keep this medication out of reach of children, and remove it from the packaging just before use.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema (including fatal outcomes)
• chest discomfort
• difficulty breathing
• angioedema
• angioedema (including fatal outcomes)
• angioedema
• angioedema (including fatal outcomes)
• angioedema.

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a sealed container to prevent air and moisture exposure and is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's effectiveness over time.

Appearance

White or almost white, both sides convex round tablet

Package unit

30 tablets (10 tablets/PTP*3)/case, 100 tablets/bottle